Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army

Generated: March 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 072695

« Back to Dashboard

NDA 072695 describes NORTREL 0.5/35-28, which is a drug marketed by Barr and is included in one NDA. It is available from two suppliers. Additional details are available on the NORTREL 0.5/35-28 profile page.

The generic ingredient in NORTREL 0.5/35-28 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for 072695
Tradename:NORTREL 0.5/35-28
Ingredient:ethinyl estradiol; norethindrone
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 072695
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
NORTREL 0.5/35-28 ethinyl estradiol; norethindrone TABLET;ORAL-28 072695 ANDA Teva Pharmaceuticals USA, Inc. 0555-9008 N 0555-9008-67
NORTREL 0.5/35-28 ethinyl estradiol; norethindrone TABLET;ORAL-28 072695 ANDA Mayne Pharma Inc. 51862-318 N 51862-318-03

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORAL-28Strength0.035MG;0.5MG
Approval Date:Feb 28, 1992TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Daiichi Sankyo
Federal Trade Commission
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.